Home » Topics » Regulatory » Patents

Patents
RSS

Chengdu Baiyu Pharmaceutical identifies new LANCL2 activators

July 12, 2022

Roche presents new Raf kinase B inhibitors

July 12, 2022

UCB SA divulges new DRD1 PAMs

July 12, 2022

Chiesi Farmaceutici discloses new ROCK inhibitors

July 12, 2022

Medshine Discovery patents compounds for fungal infections

July 12, 2022

Sunshine Lake Pharma synthesizes new GTPase KRAS inhibitors

July 11, 2022

XuanZhu Pharma identifies new AhR antagonists

July 11, 2022

Gritscience Biopharmaceuticals describes new casein kinase inhibitors

July 11, 2022

H. Lundbeck A/S discloses new NMDA glycine-site receptor modulators

July 11, 2022

Nanjing Shijiang Medicine Technology patents new compounds for cancer

July 11, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...